Cargando…
Puerarin attenuates isoproterenol-induced myocardial hypertrophy via inhibition of the Wnt/β-catenin signaling pathway
Myocardial hypertrophy (MH) is an independent risk factor for cardiovascular disease, which in turn lead to arrhythmia or heart failure. Therefore, attention must be paid to formulation of therapeutic strategies for MH. Puerarin is a key bioactive ingredient isolated from Pueraria genera of plants t...
Autores principales: | Wang, Xiaoying, He, Kai, Ma, Linlin, Wu, Lan, Yang, Yan, Li, Yanfei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9437969/ https://www.ncbi.nlm.nih.gov/pubmed/35946454 http://dx.doi.org/10.3892/mmr.2022.12822 |
Ejemplares similares
-
Exogenous Hydrogen Sulfide Supplement Attenuates Isoproterenol-Induced Myocardial Hypertrophy in a Sirtuin 3-Dependent Manner
por: Zhang, Jingyao, et al.
Publicado: (2018) -
The cardioprotective effects of the new crystal form of puerarin in isoproterenol-induced myocardial ischemia rats based on metabolomics
por: Zhou, Yuzhi, et al.
Publicado: (2020) -
Mechanism of combined use of vitamin D and puerarin in anti-hepatic fibrosis by regulating the Wnt/β-catenin signalling pathway
por: Huang, Gan-Rong, et al.
Publicado: (2018) -
Cardioprotective Effects of Puerarin-V on Isoproterenol-Induced Myocardial Infarction Mice Is Associated with Regulation of PPAR-Υ/NF-κB Pathway
por: Li, Xuguang, et al.
Publicado: (2018) -
Carbamazepine alone and in combination with doxycycline attenuates isoproterenol-induced cardiac hypertrophy
por: Errami, Mounir, et al.
Publicado: (2010)